METTL3 and neoplasm: As a promising potential tumor marker, M6A is widely used in various tumor disease research, and its close association with the clinical characteristics and prognosis of tumor patients indicates that it may be used as a therapeutic target in future tumor treatment research (An & Duan, 2022).